Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,069 | 4,743 | 3,353 | 2,491 | 1,221 |
| Operating Income | -5,069 | -4,743 | -3,353 | -2,491 | -1,221 |
| Interest Expense | 0 | 0 | 0 | 0 | 222 |
| Other Income | 98 | 140 | 181 | 162 | -2,258 |
| Pre-tax Income | -4,971 | -4,603 | -3,172 | -2,329 | -3,701 |
| Net Income Continuous | -4,971 | -4,603 | -3,172 | -2,329 | -3,701 |
| Net Income | $-4,971 | $-4,603 | $-3,172 | $-2,329 | $-3,701 |
| EPS Basic Total Ops | -0.36 | -0.34 | 0.61 | -0.17 | -1.43 |
| EPS Basic Continuous Ops | -0.36 | -0.34 | 0.39 | -0.17 | -1.05 |
| EPS Diluted Total Ops | -0.36 | -0.34 | 0.61 | -0.17 | -1.43 |
| EPS Diluted Continuous Ops | -0.36 | -0.34 | 0.39 | -0.17 | -1.05 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.34 | -0.12 | N/A | N/A |
| EBITDA(a) | $-5,063 | $-4,737 | $-3,347 | $-2,489 | $-1,036 |